Comparison between group A (response to dobutamine) and B (no response)
| Group A | Group B | p Value | |
| LVEF (%) | 24 (7) | 24 (8) | 0.90 |
| WMSI | 2.3 (0.4) | 2.1 (0.5) | 0.85 |
| MBF (ml/min/g) | 1.0 (0.2) | 1.0 (0.3) | 0.34 |
| CVR | 1.3 (0.7) | 1.1 (0.4) | 0.14 |
| FDG (μmol/min/g) | 0.40 (0.1) | 0.44 (0.1) | 0.42 |
| Heart rate, basal (beats/min) | 86 (8) | 86 (10) | 0.90 |
| Heart rate, peak (beats/min) | 98 (9) | 98 (13) | 0.70 |
| RPP, basal | 10 383 (4300) | 9471 (1353) | 0.14 |
| RPP, peak | 12 140 (2266) | 10 990 (1513) | 0.10 |
Values are mean (SD).
CVR, coronary vasodilator reserve in the biopsied region (corrected for rate–pressure product); FDG, [18F]-fluorodeoxyglucose uptake in the biopsied region; LVEF, global left ventricular ejection fraction; MBF, myocardial blood flow in the biopsied region (corrected for rate–pressure product); RPP, rate–pressure product (basal and peak dobutamine); WMSI, wall motion score index in the biopsied region.